MedTrace Logo

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

NCT02025894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3032

Last updated 2017-03-07

No results posted yet for this study

Summary

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

Conditions

Sponsors & Collaborators

  • Institut de Cancérologie de la Loire

    lead OTHER

Principal Investigators

  • Pierre Fournel, MD · Institut Cancérologique Lucien Neuwirth

  • Hervé DECOUSUS, MDPhD · CIC - CHU DE SAINT-ETIENNE

  • Franck CHAUVIN, MDPhD · Institut cancérologique Lucien Neuwirth

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02025894 on ClinicalTrials.gov